Prothena Corporation Public Limited Company Revenue per Employee (PRTA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Prothena Corporation Public Limited Company  (NASDAQ: PRTA)
 

Prothena Public Limited's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 1706.36% in the first quarter 2026, year on year to cumulative value of $58 million, Prothena Public Limited's revenue per employee grew on a trailing twelve months basis to $ 864,776. The productivity of Prothena Public Limited's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 62 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 677, from total ranking in previous quarter at 2282. Prothena Public Limited has 67 employees.


What is Sales per Employee Ratio?







PRTA Revenue per Employee (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Revenue Change 1706.36 % -99.01 % 148.97 % -96.65 % 5556 %
Sales per Employee (TTM) $ 864,776 144,537 175,910 154,343 2,058,731
PRTA's Total Ranking # 677 # 2282 # 2334 # 2782 # 908
Seq. Revenue Change 243157.14 % -99.13 % -45.36 % 56.29 % 33.21 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 45
Healthcare Sector # 63
Overall Market # 677

Revenue per Employee Statistics
High Average Low
$ 3,242,478 $ 719,532 $ 11,179
(Jun 30 2024)   (Sep 30 2020)



Financial Statements
Prothena Public Limited's Revenue MRQ $ 51 Millions Visit PRTA's Income Statement
Prothena Public Limited's Revenues TTM $ 58 Millions Visit PRTA's aggregate revenue growth
What are PRTA's Sales? Visit PRTA's Sales by Segment




Other Ratios
Prothena Public Limited's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PRTA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PRTA's Competitors
Revenue per Employee for PRTA's Suppliers
Revenue per Employee for PRTA's Customers

You may also want to know
PRTA's Sales Growth Rates PRTA's Pe Price to earnings ratio PRTA's Receivables Turnover Ratio PRTA's Stock Quote
PRTA's Net Income Growth Rates PRTA's Ps Price to Sales ratio PRTA's Sales per Employee PRTA's Asset Turnover Ratio
PRTA's Net Margin PRTA's Pb Price to Book ratio PRTA's Financial Strength Ratios PRTA's Dividend Payout Ratio
Date modified: 2026-08-29T17:19:42+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Progyny Inc   1,510,233.64 $ 1,292.760  Million 856 
Apellis Pharmaceuticals Inc   1,495,642.76 $ 1,105.280  Million 739 
Bristol myers Squibb Company  1,491,753.85 $ 48,482.000  Million 32,500 
Fennec Pharmaceuticals Inc   1,457,114.29 $ 50.999  Million 35 
Eli Lilly And Company  1,444,990.00 $ 72,249.500  Million 50,000 
Esperion Therapeutics Inc   1,422,598.64 $ 418.244  Million 294 
Krystal Biotech Inc   1,414,589.83 $ 417.304  Million 295 
Acadia Pharmaceuticals Inc   1,372,493.73 $ 1,095.250  Million 798 
Liquidia Corporation  1,333,634.26 $ 288.065  Million 216 
Biogen Inc   1,324,986.67 $ 9,937.400  Million 7,500 
Lantheus Holdings Inc   1,295,200.34 $ 1,545.174  Million 1,193 
Indivior Pharmaceuticals Inc   1,292,000.00 $ 1,292.000  Million 1,000 
Puma Biotechnology Inc   1,269,150.84 $ 227.178  Million 179 
Madrigal Pharmaceuticals Inc   1,237,693.99 $ 1,132.490  Million 915 
Theravance Biopharma inc   1,219,722.22 $ 109.775  Million 90 
Akebia Therapeutics Inc   1,197,958.76 $ 232.404  Million 194 
Supernus Pharmaceuticals inc   1,191,461.66 $ 776.833  Million 652 
Arcutis Biotherapeutics Inc   1,174,079.10 $ 415.624  Million 354 
Heron Therapeutics Inc   1,173,312.50 $ 150.184  Million 128 
Cue Biopharma Inc   1,128,655.17 $ 32.731  Million 29 
Journey Medical Corp  1,115,172.41 $ 64.680  Million 58 
Abbvie Inc   1,102,087.72 $ 62,819.000  Million 57,000 
Travere Therapeutics Inc   1,078,863.18 $ 536.195  Million 497 
Corcept Therapeutics Inc  1,053,556.16 $ 769.096  Million 730 
Biomarin Pharmaceutical Inc  1,006,617.82 $ 3,242.316  Million 3,221 
Scilex Holding Company  995,941.18 $ 33.862  Million 34 
Coya Therapeutics Inc   992,377.00 $ 7.939  Million
Sanara Medtech Inc   989,563.23 $ 106.873  Million 108 
Assembly Biosciences Inc   973,931.51 $ 71.097  Million 73 
Hims and Hers Health Inc   970,301.39 $ 2,369.476  Million 2,442 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.